Literature DB >> 27866281

Reversible lesion involving the splenium of the corpus callosum caused by phenytoin sodium withdrawal.

Lingling Wang1, Xiaoshan Wang1, Xiangsong Shi2, Wenchao Qiu1, Ailiang Miao3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27866281     DOI: 10.1007/s10072-016-2773-9

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  5 in total

1.  Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal.

Authors:  Rosa Cortese; Giuseppe Pontrelli; Maria Paola Mogavero; Franca Dicuonzo; Carla Tortorella
Journal:  Neurol Sci       Date:  2015-03-13       Impact factor: 3.307

2.  Transient edematous lesions of the splenium in epileptic patients.

Authors:  Giovanna Carrara; Edoardo Ferlazzo; Donatella Tampieri; Frederick Andermann; Denis Melanson
Journal:  Can J Neurol Sci       Date:  2005-08       Impact factor: 2.104

Review 3.  Reversible splenial lesion syndrome (RESLES): what's in a name?

Authors:  Juan Carlos Garcia-Monco; Ines Escalza Cortina; Eva Ferreira; Amaia Martínez; Lara Ruiz; Alberto Cabrera; Marian Gomez Beldarrain
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

4.  Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults: a retrospective study of a rare entity.

Authors:  Shuo Zhang; Yan Ma; Juan Feng
Journal:  Medicine (Baltimore)       Date:  2015-02       Impact factor: 1.889

Review 5.  Systemic therapies for inflammatory eye disease: past, present and future.

Authors:  Alastair K Denniston; Andrew D Dick
Journal:  BMC Ophthalmol       Date:  2013-04-24       Impact factor: 2.209

  5 in total
  1 in total

1.  Reversible Splenial Lesion Syndrome with Some Novel Causes and Clinical Manifestations.

Authors:  Pei-Lin Lu; John F Hodes; Xu Zheng; Xing-Yue Hu
Journal:  Intern Med       Date:  2020-06-30       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.